ClinicalTrials.govpublic full text
A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40mg
gastro-oesophageal reflux, gastroesophageal reflux, heartburn, proton pump inhibitor, gord, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 966094
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.